Nyxoah SA (EBR:NYXH)
Belgium · Delayed Price · Currency is EUR 2.715
+0.060 (2.26%)
At close: Mar 20, 2026
Nyxoah Market Cap
Nyxoah has a market cap or net worth of €116.82 million as of March 20, 2026. Its market cap has decreased by -66.37% in one year.
Market Cap
116.82M
Enterprise Value
110.89M
Revenue
10.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.72
Market Cap Chart
Since September 18, 2020, Nyxoah's market cap has decreased from 417.77M to 116.82M, a decrease of -72.04%. That is a compound annual growth rate of -20.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 116.82M | -33.54% |
| Dec 31, 2025 | 175.76M | -43.15% |
| Dec 31, 2024 | 309.15M | 153.09% |
| Dec 29, 2023 | 122.15M | -8.05% |
| Dec 30, 2022 | 132.85M | -72.29% |
| Dec 31, 2021 | 479.37M | 37.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 46.94B |
| argenx SE | 36.29B |
| Financière de Tubize | 9.08B |
| Fagron NV | 1.59B |
| Ion Beam Applications | 394.24M |
| Onward Medical | 193.79M |
| Hyloris Pharmaceuticals | 157.36M |
| Sequana Medical NV | 36.00M |